Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising – CNBC

Novo asked the court to permanently stop Lilly from running the “deceptive” ads and require the drugmaker to issue corrective advertising.

#stockmarket #breaking

Leave a Reply

WP Twitter Auto Publish Powered By : XYZScripts.com